New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts

Gianluca Rigatelli, Katia Rossini, Vincenzo Vindigni, Francesco Mazzoleni, Giorgio Rigatelli, Ugo Carraro

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Autologous skeletal myoblast transplantation may be used to ameliorate the healing process following myocardium infarct and, hopefully, cardiomyopathies. Despite successful animal experimentation, several issues need to be addressed in clinical settings, i.e., the impact of the delivery route, the extent of short- and long-term survival, and differentiation of the injected skeletal myoblasts. The authors offer some new hypotheses resulting from basic research, i.e., where and when to inject the myogenic cells, whatever their source, how to decrease new myofiber atrophy and improve their regeneration. Although these new hypotheses still need to be tested in humans, they may be decisive for future experimental studies and will lead to making endovascular cell implantation a more effective way to treat ischemic heart disease and failure.

Original languageEnglish
Pages (from-to)84-87
Number of pages4
JournalCardiovascular Radiation Medicine
Volume5
Issue number2
DOIs
Publication statusPublished - Apr 2004

Fingerprint

Skeletal Myoblasts
Myocardium
Cardiomyopathies
Atrophy
Myocardial Ischemia
Regeneration
Heart Failure
Transplantation
Survival
Research

Keywords

  • Cellular cardiomyoplasty
  • Myocardial infarction
  • Skeletal myofiber regeneration
  • Stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts. / Rigatelli, Gianluca; Rossini, Katia; Vindigni, Vincenzo; Mazzoleni, Francesco; Rigatelli, Giorgio; Carraro, Ugo.

In: Cardiovascular Radiation Medicine, Vol. 5, No. 2, 04.2004, p. 84-87.

Research output: Contribution to journalArticle

Rigatelli, G, Rossini, K, Vindigni, V, Mazzoleni, F, Rigatelli, G & Carraro, U 2004, 'New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts', Cardiovascular Radiation Medicine, vol. 5, no. 2, pp. 84-87. https://doi.org/10.1016/j.carrad.2004.05.003
Rigatelli, Gianluca ; Rossini, Katia ; Vindigni, Vincenzo ; Mazzoleni, Francesco ; Rigatelli, Giorgio ; Carraro, Ugo. / New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts. In: Cardiovascular Radiation Medicine. 2004 ; Vol. 5, No. 2. pp. 84-87.
@article{b40565528bdd40e7a2f78f3ca001112f,
title = "New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts",
abstract = "Autologous skeletal myoblast transplantation may be used to ameliorate the healing process following myocardium infarct and, hopefully, cardiomyopathies. Despite successful animal experimentation, several issues need to be addressed in clinical settings, i.e., the impact of the delivery route, the extent of short- and long-term survival, and differentiation of the injected skeletal myoblasts. The authors offer some new hypotheses resulting from basic research, i.e., where and when to inject the myogenic cells, whatever their source, how to decrease new myofiber atrophy and improve their regeneration. Although these new hypotheses still need to be tested in humans, they may be decisive for future experimental studies and will lead to making endovascular cell implantation a more effective way to treat ischemic heart disease and failure.",
keywords = "Cellular cardiomyoplasty, Myocardial infarction, Skeletal myofiber regeneration, Stem cells",
author = "Gianluca Rigatelli and Katia Rossini and Vincenzo Vindigni and Francesco Mazzoleni and Giorgio Rigatelli and Ugo Carraro",
year = "2004",
month = "4",
doi = "10.1016/j.carrad.2004.05.003",
language = "English",
volume = "5",
pages = "84--87",
journal = "Cardiovascular Radiation Medicine",
issn = "1522-1865",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts

AU - Rigatelli, Gianluca

AU - Rossini, Katia

AU - Vindigni, Vincenzo

AU - Mazzoleni, Francesco

AU - Rigatelli, Giorgio

AU - Carraro, Ugo

PY - 2004/4

Y1 - 2004/4

N2 - Autologous skeletal myoblast transplantation may be used to ameliorate the healing process following myocardium infarct and, hopefully, cardiomyopathies. Despite successful animal experimentation, several issues need to be addressed in clinical settings, i.e., the impact of the delivery route, the extent of short- and long-term survival, and differentiation of the injected skeletal myoblasts. The authors offer some new hypotheses resulting from basic research, i.e., where and when to inject the myogenic cells, whatever their source, how to decrease new myofiber atrophy and improve their regeneration. Although these new hypotheses still need to be tested in humans, they may be decisive for future experimental studies and will lead to making endovascular cell implantation a more effective way to treat ischemic heart disease and failure.

AB - Autologous skeletal myoblast transplantation may be used to ameliorate the healing process following myocardium infarct and, hopefully, cardiomyopathies. Despite successful animal experimentation, several issues need to be addressed in clinical settings, i.e., the impact of the delivery route, the extent of short- and long-term survival, and differentiation of the injected skeletal myoblasts. The authors offer some new hypotheses resulting from basic research, i.e., where and when to inject the myogenic cells, whatever their source, how to decrease new myofiber atrophy and improve their regeneration. Although these new hypotheses still need to be tested in humans, they may be decisive for future experimental studies and will lead to making endovascular cell implantation a more effective way to treat ischemic heart disease and failure.

KW - Cellular cardiomyoplasty

KW - Myocardial infarction

KW - Skeletal myofiber regeneration

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=5344257545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5344257545&partnerID=8YFLogxK

U2 - 10.1016/j.carrad.2004.05.003

DO - 10.1016/j.carrad.2004.05.003

M3 - Article

VL - 5

SP - 84

EP - 87

JO - Cardiovascular Radiation Medicine

JF - Cardiovascular Radiation Medicine

SN - 1522-1865

IS - 2

ER -